Jaman Maroni

2.9k total citations · 1 hit paper
31 papers, 2.0k citations indexed

About

Jaman Maroni is a scholar working on Physiology, Surgery and Immunology. According to data from OpenAlex, Jaman Maroni has authored 31 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 11 papers in Surgery and 9 papers in Immunology. Recurrent topics in Jaman Maroni's work include Asthma and respiratory diseases (18 papers), IL-33, ST2, and ILC Pathways (8 papers) and Dermatology and Skin Diseases (7 papers). Jaman Maroni is often cited by papers focused on Asthma and respiratory diseases (18 papers), IL-33, ST2, and ILC Pathways (8 papers) and Dermatology and Skin Diseases (7 papers). Jaman Maroni collaborates with scholars based in United States, France and United Kingdom. Jaman Maroni's co-authors include John J.P. Kastelein, Antonio M. Gotto, Vera Bittner, John C. LaRosa, Jean‐Charles Fruchart, Michael Szarek, Scott M. Grundy, Philip J. Barter, Paul Rowe and Nikhil Amin and has published in prestigious journals such as New England Journal of Medicine, Circulation and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Jaman Maroni

31 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

2007 1.2k citations Philip J. Barter, Antonio M. Gotto et al. New England Journal of Medicine profile →

Peers

Jaman Maroni

SURGE

EDM

PHYSI

CCM

PRM

Melton B. Affrime United States

Darcy A. Hille United States

Eyal Leibovitz Israel

Corinne Frère France

Yap‐Hang Chan Hong Kong

Jonathan M. Edelman United States

Xiao‐Mei Li China

Hieronymus A.M. Voorbij Netherlands

Tatsushi Omatsu Japan

Žhong Yuan United States

Melton B. Affrime United States

Jaman Maroni

277 ×0.3

SURGE

123 ×0.2

EDM

611 ×1.5

PHYSI

241 ×0.6

CCM

339 ×1.3

PRM

Citations per year, relative to Jaman Maroni Jaman Maroni (= 1×) peers Melton B. Affrime

Countries citing papers authored by Jaman Maroni

Since Specialization

Citations

This map shows the geographic impact of Jaman Maroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaman Maroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaman Maroni more than expected).

Fields of papers citing papers by Jaman Maroni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaman Maroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaman Maroni. The network helps show where Jaman Maroni may publish in the future.

Co-authorship network of co-authors of Jaman Maroni

This figure shows the co-authorship network connecting the top 25 collaborators of Jaman Maroni. A scholar is included among the top collaborators of Jaman Maroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaman Maroni. Jaman Maroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Máspero, Jorge, Anju T. Peters, Kenneth R. Chapman, et al.. (2023). Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 991–997.e6. 8 indexed citations

Khan, Asif, Laurent Eckert, Caroline Amand, et al.. (2022). Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma. Journal of Asthma and Allergy. Volume 15. 1639–1644. 1 indexed citations

Castro, Mario, Klaus F. Rabe, Jonathan Corren, et al.. (2020). Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma. ERJ Open Research. 6(1). 204–2019. 38 indexed citations

Corren, Jonathan, Mario Castro, Linda B. Ford, et al.. (2019). Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history. Annals of Allergy Asthma & Immunology. 123(2). 222–224.e1. 15 indexed citations

Wenzel, Sally E., Ian Pavord, Jaman Maroni, et al.. (2018). Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST. American Journal of Respiratory and Critical Care Medicine. 197. 12 indexed citations

Weinstein, Steven F., Rohit Katial, Shyamalie Jayawardena, et al.. (2018). Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma. Journal of Allergy and Clinical Immunology. 142(1). 171–177.e1. 98 indexed citations

Máspero, Jorge, Mark Fitzgerald, Ian Pavord, et al.. (2018). DUPILUMAB REDUCES SEVERE EXACERBATION RATE AND IMPROVES LUNG FUNCTION IN ADOLESCENT PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: FROM THE LIBERTY ASTHMA QUEST STUDY. CHEST Journal. 154(4). 25A–27A. 12 indexed citations

Cariou, Bertrand, Lawrence A. Leiter, Dirk Müller‐Wieland, et al.. (2017). Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial. Diabetes & Metabolism. 43(5). 453–459. 19 indexed citations

Müller‐Wieland, Dirk, Lawrence A. Leiter, Bertrand Cariou, et al.. (2017). Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk. Cardiovascular Diabetology. 16(1). 70–70. 21 indexed citations

10.

Jayawardena, Shyamalie, Paul Rowe, Jaman Maroni, et al.. (2017). P58: DUPILUMAB EFFICACY AND EFFECT ON ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED PERSISTENT ASTHMA AND COMORBID CHRONIC RHINOSINUSITIS WITH OR WITHOUT NASAL POLYPS. Internal Medicine Journal. 47(S5). 22–22. 5 indexed citations

11.

Katial, Rohit, Vijay N. Joish, Nikhil Amin, et al.. (2017). Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis. PA3551–PA3551. 3 indexed citations

12.

Bernstein, J, Linda Ford, Shyamalie Jayawardena, et al.. (2017). P204 Dupilumab reduces exacerbations and improves lung function in uncontrolled persistent asthma patients across baseline exacerbations. Annals of Allergy Asthma & Immunology. 119(5). S50–S50. 2 indexed citations

13.

Kastelein, John J.P., Dean J. Kereiakes, Christopher P. Cannon, et al.. (2016). Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia. Coronary Artery Disease. 28(3). 190–197. 21 indexed citations

14.

Barter, Philip J., Antonio M. Gotto, John C. LaRosa, et al.. (2007). HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events. New England Journal of Medicine. 357(13). 1301–1310. 1209 indexed citations breakdown →

15.

Freeman, Daryl, Robert J. Nordyke, Sharon Isonaka, et al.. (2005). Questions for COPD diagnostic screening in a primary care setting. Respiratory Medicine. 99(10). 1311–1318. 56 indexed citations

16.

Blank, Roy C., James LaSalle, Russell A. Reeves, et al.. (2005). Single‐Pill Therapy in the Treatment of Concomitant Hypertension and Dyslipidemia (The Amlodipine/Atorvastatin Gemini Study). Journal of Clinical Hypertension. 7(5). 264–273. 59 indexed citations

17.

Schayck, Constant P. van, Ronald J. Halbert, Robert J. Nordyke, et al.. (2005). Comparison of existing symptom‐based questionnaires for identifying COPD in the general practice setting. Respirology. 10(3). 323–333. 53 indexed citations

18.

Crystal, Ronald G., Ben‐Gary Harvey, Juan P. Wisnivesky, et al.. (2002). Analysis of Risk Factors for Local Delivery of Low- and Intermediate-Dose Adenovirus Gene Transfer Vectors to Individuals with a Spectrum of Comorbid Conditions. Human Gene Therapy. 13(1). 65–100. 62 indexed citations

19.

Harvey, Ben‐Gary, Jaman Maroni, Karen Chu, et al.. (2002). Safety of Local Delivery of Low- and Intermediate-Dose Adenovirus Gene Transfer Vectors to Individuals with a Spectrum of Morbid Conditions. Human Gene Therapy. 13(1). 15–63. 98 indexed citations

20.

Maroni, Jaman, et al.. (1998). Maximum Cardiac Output During Incremental Exercise by First-pass Radionuclide Ventriculography. CHEST Journal. 114(2). 457–461. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact